Whole-exome sequencing (WES) analysis of 28 (2 additional tumors underwent multiplex PCR testing for MEN1) tumors from 17 patients did not reveal any recurrent variants in 2 or more tumors or tumor and germline DNA. The gene discussed is MEN1; the disease is neoplasm.